MARKET RADAR
SENSEX     NIFTY      
GlaxoSmithKline Pharmaceuticals Homepage >> Stock Price >> GlaxoSmithKline >> Pharmaceuticals >> Price/Quote, Highs, Lows, Volumes, Graphs, Bid, Offers, Historic Prices, Financials, Income, Results, Mutual Funds, Background, Management, News, Views, Actions, Interviews, Messages

GlaxoSmithKline Pharmaceuticals

  BSE: 500660  |  NSE: GLAXO  |  ISIN: INE159A01016
    
Add to Portfolio : Buy Date Qty Price |
2,032.95 -9.25 (-0.45%)
BSE : Feb 10, 17:00
Open 2,050.10 Vol 1,275
High 2,050.10 52 Wk 2,475.00
Low 2,032.00 52 Wk 1,830.00
Prev. Close 2,042.20    
2,034.55 -4.70 (-0.23%)
NSE : Feb 10, 17:00
Open 2,035.10 Vol 13,930
High 2,055.00 52 Wk 2,478.00
Low 2,029.90 52 Wk 1,811.10
Prev. Close 2,039.25    
- Related links
Track GlaxoSmithKline Pharmaceuticals 24x7
Get price sensitive and timely news updates on your mobile for just Re 1 a day
Activate Now
  Bid Offer
Price 0.00 0.00
Quantity 0.00 0.00
  Bid Offer
Price 0.00 2,034.55
Quantity 0.00 1.00
Market Cap 17,219.70 | * EPS (TTM) 48.35 | * P/E 42.05 | * P/C 40.31
* Book Value 227.95 | * Price/Book 8.92 | Div(%) 400.00 | Div Yield(%) 1.97
Market Lot 1.00 | Face Value 10.00 | Industry P/E 11.00
* As per latest stand alone adjusted profit after extra-ordinary items.

F&O Quote of GlaxoSmithKline

Historic Prices of GlaxoSmithKline

on 1 week 1 month 3 month 1 year 2 year 3 year
1 YearCurrent% Gain/Loss
Open Price 2176.002050.10
High Price 2222.002050.10
Low Price 2162.002032.00
Last Price 2210.452032.95-8.03
Volume33211275-61.61

Financials of GlaxoSmithKline

Income Statement (Sep '11) (Dec '10)
  Quarterly Annual
Net Sales 613.80 2146.43
Other Income 0.00 18.00
PBDIT 183.04 788.19
Net Profit 145.86 563.69
Profit & Loss | Half Yearly Results | Quarterly Results
Balance Sheet
Total Share Capital 84.70
Net Worth 1930.81
Total Debt 5.16
Net Block 108.93
Investments 160.35
Net Current Assets 1657.96
Total Assets 1935.96
Balance Sheet | Finished Goods | Raw Materials

Mutual Funds Holding - GlaxoSmithKline

Compare with Peers

What's your call on GlaxoSmithKline

Experience the thrills of
investing with no risk

Community on GlaxoSmithKline

News Events - GlaxoSmithKline

BSE / NSE Notices - GlaxoSmithKline

Expert Advice - GlaxoSmithKline

No Expert Advice in the last 7 days

Queries on GlaxoSmithKline

Groups: Pharmaceuticals

Company Last Price Market Cap
Sun Pharma 541.30 56,056.05
Cipla 349.00 28,021.96
Dr Reddys Labs 1,619.85 27,452.54
Lupin 458.80 20,487.26
Ranbaxy Labs 443.30 18,679.03
more...

Compare with peers

Simple Moving Averages - GlaxoSmithKline

Days BSE NSE
30 1969.59 1972.04
50 1939.07 1940.77
150 2063.43 2064.34
200 2131.62 2132.77

Company Facts - GlaxoSmithKline

Registered Address

Dr. Annie Besant Road
,
Mumbai
Maharashtra
400030

Tel: 022-24959595
Fax: 022-24959494
Email: ajay.a.nadkarni@gsk.com
Website: http://www.gsk-india.com

Registrars

Glaxosmithkline Consumer Healthcare Ltd. DLF Plaza Tower
DLF City, Phase I


Gurgaon - 122002
Haryana

Tel: 0124-26540700-03
Fax: 0124-0124-26540720
Email:
Website:

Management - GlaxoSmithKline

Name Designation
D S Parekh Chairman / Chair Person
H B Joshipura Managing Director
A Banerjee Director
S Harford Director
N Kaviratne Director
P V Nayak Director
D Sundaram Director
Ashoke Banerjee Alternate Director
Name Designation
V Thyagarajan Vice Chairman
R R Bajaaj Director
P V Bhide Director
M B Kapadia Director
V Narayanan Director
R C Sequeira Director
Raju Krishnaswamy Executive Director
A N Roy Non Exe.Ind.Addnl.Director
Type
S GlaxoSmithKline
SMS to 51818 you
will receive the latest quote on both BSE & NSE.
Announcements
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends
Information
Company History
Background
Board of Directors
Capital Structure
Listing Info
Locations
Bulk Deals
Block Deals
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Half Yearly Results
Nine Monthly Results
Yearly Results
Cash Flow
Annual Report
Directors Report
Chairman's Speech
Auditors Report
Notes to Accounts
Finished Goods
Raw Materials
Peer Comparison
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets
Exports grow 10.1% in Jan. Will exports take a setback in the coming months?
Yes
No
 

Follow moneycontrol.com